Tissue Regenix Group plc (TRX.L)
GBp 31.0
(-6.63%)
GBp 31.0
(-6.63%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -394 Thousand GBP | 80.34% |
| 2022 | -1.61 Million USD | 45.94% |
| 2021 | -2.98 Million USD | 27.55% |
| 2020 | -4.11 Million GBP | 42.66% |
| 2019 | -7.18 Million GBP | 12.56% |
| 2018 | -8.21 Million GBP | 13.15% |
| 2017 | -9.45 Million GBP | 22.45% |
| 2016 | -12.19 Million GBP | 16.42% |
| 2015 | -14.58 Million GBP | -74.86% |
| 2014 | -8.34 Million GBP | 23.11% |
| 2013 | -10.84 Million GBP | -55.68% |
| 2012 | -6.96 Million GBP | -48.52% |
| 2011 | -4.69 Million GBP | 47.92% |
| 2010 | -9 Million GBP | -4204.74% |
| 2009 | -209.28 Thousand GBP | 93.64% |
| 2008 | -3.28 Million GBP | -600.86% |
| 2007 | -469.28 Thousand GBP | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 413.5 Thousand GBP | 0.0% |
| 2023 Q4 | -125.5 Thousand GBP | 0.0% |
| 2023 Q2 | -189.75 Thousand GBP | 0.0% |
| 2023 FY | -316.96 Thousand GBP | 80.34% |
| 2022 FY | -1.61 Million USD | 45.94% |
| 2022 Q4 | -617.39 Thousand GBP | 0.0% |
| 2022 Q2 | -991.34 Thousand GBP | 0.0% |
| 2021 Q2 | -1.33 Million GBP | 0.0% |
| 2021 FY | -2.98 Million USD | 27.55% |
| 2020 FY | -4.11 Million GBP | 42.66% |
| 2020 Q4 | -1.75 Million GBP | 0.0% |
| 2020 Q2 | -2.42 Million GBP | 0.0% |
| 2019 Q2 | -4.17 Million GBP | 0.0% |
| 2019 Q4 | -2.99 Million GBP | 0.0% |
| 2019 FY | -7.18 Million GBP | 12.56% |
| 2018 Q4 | -4.03 Million GBP | 0.0% |
| 2018 FY | -8.21 Million GBP | 13.15% |
| 2017 FY | -9.45 Million GBP | 22.45% |
| 2016 FY | -12.19 Million GBP | 16.42% |
| 2015 FY | -14.58 Million GBP | -74.86% |
| 2014 FY | -8.34 Million GBP | 23.11% |
| 2013 FY | -10.84 Million GBP | -55.68% |
| 2012 Q3 | -731.5 Thousand GBP | 0.0% |
| 2012 Q2 | -731.5 Thousand GBP | 0.0% |
| 2012 Q1 | -731.5 Thousand GBP | 0.0% |
| 2012 FY | -6.96 Million GBP | -48.52% |
| 2012 Q4 | -993 Thousand GBP | -35.75% |
| 2011 Q1 | -1.41 Million GBP | 0.0% |
| 2011 FY | -4.69 Million GBP | 47.92% |
| 2011 Q4 | -731.5 Thousand GBP | 48.35% |
| 2011 Q3 | -1.41 Million GBP | 0.0% |
| 2011 Q2 | -1.41 Million GBP | 0.0% |
| 2010 FY | -9 Million GBP | -4204.74% |
| 2010 Q2 | -57.25 Thousand GBP | 0.0% |
| 2010 Q4 | -1.41 Million GBP | -2373.8% |
| 2010 Q3 | -57.25 Thousand GBP | 0.0% |
| 2010 Q1 | -57.25 Thousand GBP | 0.0% |
| 2009 Q1 | -587.75 Thousand GBP | 0.0% |
| 2009 Q4 | -57.25 Thousand GBP | 90.26% |
| 2009 Q2 | -587.75 Thousand GBP | 0.0% |
| 2009 FY | -209.28 Thousand GBP | 93.64% |
| 2009 Q3 | -587.75 Thousand GBP | 0.0% |
| 2008 FY | -3.28 Million GBP | -600.86% |
| 2008 Q4 | -587.75 Thousand GBP | -3953.45% |
| 2008 Q2 | -14.5 Thousand GBP | 0.0% |
| 2008 Q1 | -14.5 Thousand GBP | 0.0% |
| 2008 Q3 | -14.5 Thousand GBP | 0.0% |
| 2007 Q1 | - GBP | 0.0% |
| 2007 Q2 | - GBP | 0.0% |
| 2007 Q3 | - GBP | 0.0% |
| 2007 Q4 | -14.5 Thousand GBP | 0.0% |
| 2007 FY | -469.28 Thousand GBP | 0.0% |
| 2006 Q4 | - GBP | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|